Alimera Sciences, Inc.

Alimera Sciences, Inc.verified

ALIM

Price:

$5.54

Market Cap:

$301.29M

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2019-11-04

Stock Exchange

NASDAQ

Ticker

ALIM

The ROE as of November 2024 (TTM) for Alimera Sciences, Inc. (ALIM) is -33.70%

According to Alimera Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.70%. This represents a change of 286.52% compared to the average of -8.72% of the last 4 quarters.

Alimera Sciences, Inc. (ALIM) Historical ROE (quarterly & annually)

How has ALIM ROE performed in the past?

The mean historical ROE of Alimera Sciences, Inc. over the last ten years is -55.50%. The current -33.70% ROE has changed -39.28% with respect to the historical average. Over the past ten years (40 quarters), ALIM's ROE was at its highest in in the December 2021 quarter at 157.62%. The ROE was at its lowest in in the March 2019 quarter at -427.71%.

Quarterly (TTM)
Annual

Average

-55.50%

Median

-58.06%

Minimum

-601.87%

Maximum

234.94%

Alimera Sciences, Inc. (ALIM) ROE by Quarter and Year

Discovering the peaks and valleys of Alimera Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 308.13%

Maximum Annual ROE = 234.94%

Minimum Annual Increase = -150.20%

Minimum Annual ROE = -601.87%

Quarterly (TTM)
Annual
YearROEChange
2023-43.60%-150.20%
202286.85%-48.25%
2021167.83%150.79%
202066.92%-71.52%
2019234.94%-139.03%
2018-601.87%308.13%
2017-147.47%13.74%
2016-129.66%11.36%
2015-116.43%60.56%
2014-72.52%-107.73%

Alimera Sciences, Inc. (ALIM) Average ROE

How has ALIM ROE performed in the past?

The current ROE of Alimera Sciences, Inc. (ALIM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

70.36%

5-year avg

102.59%

10-year avg

-55.50%

Alimera Sciences, Inc. (ALIM) ROE vs. Peers

How is ALIM’s ROE compared to its peers?

Alimera Sciences, Inc.’s ROE is greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), less than Lifecore Biomedical, Inc. (17.23%), greater than Mallinckrodt plc (-74.45%), greater than Journey Medical Corporation (-132.10%), greater than Lucy Scientific Discovery Inc. (-296.96%), less than Adamis Pharmaceuticals Corporation (0.33%), greater than Organogenesis Holdings Inc. (-2.69%), less than Cyclo Therapeutics, Inc. (749.85%), less than Athenex, Inc. (21.51%), greater than MedMen Enterprises Inc. (-96.37%), greater than China Pharma Holdings, Inc. (-63.93%), greater than Halo Collective Inc. (-165.53%), greater than China SXT Pharmaceuticals, Inc. (-83.62%), greater than Petros Pharmaceuticals, Inc. (-122.55%),

Build a custom stock screener for Alimera Sciences, Inc. (ALIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alimera Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alimera Sciences, Inc. (ALIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alimera Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Alimera Sciences, Inc.'s ROE?

How is the ROE calculated for Alimera Sciences, Inc. (ALIM)?

What is the highest ROE for Alimera Sciences, Inc. (ALIM)?

What is the 3-year average ROE for Alimera Sciences, Inc. (ALIM)?

What is the 5-year average ROE for Alimera Sciences, Inc. (ALIM)?

How does the current ROE for Alimera Sciences, Inc. (ALIM) compare to its historical average?